Bri-Chem（BRY）株式概要ブリ・ケム・コーポレーションは、その子会社とともに、北米の石油・ガス産業向けに油田用化学品の卸販売を行っている。 詳細BRY ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績3/6財務の健全性4/6配当金0/6報酬当社が推定した公正価値より89.6%で取引されている 今年は黒字化を達成 リスク分析利払いは収益で十分にカバーされない 意味のある時価総額がありません ( CA$10M )すべてのリスクチェックを見るBRY Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW483,856 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA483,856 investors already sharing narrativesYour Fair ValueCA$Current PriceCA$0.3719.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-17m118m2016201920222025202620282031Revenue CA$98.7mEarnings CA$2.0mAdvancedSet Fair ValueView all narrativesBri-Chem Corp. 競合他社GoodfellowSymbol: TSX:GDLMarket cap: CA$93.7mEnterprise GroupSymbol: TSX:EMarket cap: CA$124.9mRektron GroupSymbol: CNSX:REK.UMarket cap: US$154.2mTaiga Building ProductsSymbol: TSX:TBLMarket cap: CA$391.8m価格と性能株価の高値、安値、推移の概要Bri-Chem過去の株価現在の株価CA$0.3752週高値CA$0.4452週安値CA$0.20ベータ-0.751ヶ月の変化12.12%3ヶ月変化2.78%1年変化12.12%3年間の変化-7.50%5年間の変化89.74%IPOからの変化-81.50%最新ニュースNew Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Market cap is less than US$10m (CA$9.38m market cap, or US$6.59m). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).Reported Earnings • May 15First quarter 2026 earnings released: EPS: CA$0.01 (vs CA$0.016 loss in 1Q 2025)First quarter 2026 results: EPS: CA$0.01 (up from CA$0.016 loss in 1Q 2025). Revenue: CA$16.6m (down 17% from 1Q 2025). Net income: CA$86.4k (up CA$498.1k from 1Q 2025). Profit margin: 0.5% (up from net loss in 1Q 2025). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.お知らせ • Apr 16Bri-Chem Corp., Annual General Meeting, Jun 19, 2026Bri-Chem Corp., Annual General Meeting, Jun 19, 2026. Location: british columbia, vancouver CanadaReported Earnings • Mar 27Full year 2025 earnings released: EPS: CA$0.04 (vs CA$0.15 loss in FY 2024)Full year 2025 results: EPS: CA$0.04 (up from CA$0.15 loss in FY 2024). Revenue: CA$75.6m (down 9.0% from FY 2024). Net income: CA$979.0k (up CA$4.83m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 18Third quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.01 loss in 3Q 2024)Third quarter 2025 results: EPS: CA$0.01 (up from CA$0.01 loss in 3Q 2024). Revenue: CA$18.2m (down 17% from 3Q 2024). Net income: CA$160.3k (up CA$429.1k from 3Q 2024). Profit margin: 0.9% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • Oct 21Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.3% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.最新情報をもっと見るRecent updatesNew Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Market cap is less than US$10m (CA$9.38m market cap, or US$6.59m). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).Reported Earnings • May 15First quarter 2026 earnings released: EPS: CA$0.01 (vs CA$0.016 loss in 1Q 2025)First quarter 2026 results: EPS: CA$0.01 (up from CA$0.016 loss in 1Q 2025). Revenue: CA$16.6m (down 17% from 1Q 2025). Net income: CA$86.4k (up CA$498.1k from 1Q 2025). Profit margin: 0.5% (up from net loss in 1Q 2025). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.お知らせ • Apr 16Bri-Chem Corp., Annual General Meeting, Jun 19, 2026Bri-Chem Corp., Annual General Meeting, Jun 19, 2026. Location: british columbia, vancouver CanadaReported Earnings • Mar 27Full year 2025 earnings released: EPS: CA$0.04 (vs CA$0.15 loss in FY 2024)Full year 2025 results: EPS: CA$0.04 (up from CA$0.15 loss in FY 2024). Revenue: CA$75.6m (down 9.0% from FY 2024). Net income: CA$979.0k (up CA$4.83m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 18Third quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.01 loss in 3Q 2024)Third quarter 2025 results: EPS: CA$0.01 (up from CA$0.01 loss in 3Q 2024). Revenue: CA$18.2m (down 17% from 3Q 2024). Net income: CA$160.3k (up CA$429.1k from 3Q 2024). Profit margin: 0.9% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • Oct 21Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.3% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Oct 18Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.3% to CA$0.22. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Sep 15Now 24% undervaluedOver the last 90 days, the stock has risen 4.7% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.018 loss in 2Q 2024)Second quarter 2025 results: EPS: CA$0.01 (up from CA$0.018 loss in 2Q 2024). Revenue: CA$20.5m (up 7.5% from 2Q 2024). Net income: CA$156.8k (up CA$644.6k from 2Q 2024). Profit margin: 0.8% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.分析記事 • Jul 30A Piece Of The Puzzle Missing From Bri-Chem Corp.'s (TSE:BRY) 48% Share Price ClimbBri-Chem Corp. ( TSE:BRY ) shareholders would be excited to see that the share price has had a great month, posting a...Reported Earnings • May 17First quarter 2025 earnings released: CA$0.02 loss per share (vs CA$0.057 loss in 1Q 2024)First quarter 2025 results: CA$0.02 loss per share (improved from CA$0.057 loss in 1Q 2024). Revenue: CA$19.9m (down 6.8% from 1Q 2024). Net loss: CA$411.8k (loss narrowed 73% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance.お知らせ • Apr 16Bri-Chem Corp., Annual General Meeting, Jun 20, 2025Bri-Chem Corp., Annual General Meeting, Jun 20, 2025. Location: alberta, edmonton CanadaReported Earnings • Apr 01Full year 2024 earnings released: CA$0.15 loss per share (vs CA$0.034 profit in FY 2023)Full year 2024 results: CA$0.15 loss per share (down from CA$0.034 profit in FY 2023). Revenue: CA$83.1m (down 22% from FY 2023). Net loss: CA$3.85m (down CA$4.76m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.分析記事 • Dec 13Investors Still Aren't Entirely Convinced By Bri-Chem Corp.'s (TSE:BRY) Revenues Despite 59% Price JumpBri-Chem Corp. ( TSE:BRY ) shares have had a really impressive month, gaining 59% after a shaky period beforehand...Reported Earnings • Nov 17Third quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.014 loss in 3Q 2023)Third quarter 2024 results: CA$0.01 loss per share (improved from CA$0.014 loss in 3Q 2023). Revenue: CA$22.0m (down 18% from 3Q 2023). Net loss: CA$268.8k (loss narrowed 28% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.分析記事 • Sep 10Some Investors May Be Worried About Bri-Chem's (TSE:BRY) Returns On CapitalIf you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...Reported Earnings • Aug 16Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.021 profit in 2Q 2023)Second quarter 2024 results: CA$0.02 loss per share (down from CA$0.021 profit in 2Q 2023). Revenue: CA$19.1m (down 24% from 2Q 2023). Net loss: CA$487.8k (down 188% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.分析記事 • May 22Bri-Chem (TSE:BRY) Hasn't Managed To Accelerate Its ReturnsIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Reported Earnings • May 19First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.01 profit in 1Q 2023)First quarter 2024 results: CA$0.06 loss per share (down from CA$0.01 profit in 1Q 2023). Revenue: CA$21.4m (down 21% from 1Q 2023). Net loss: CA$1.51m (down CA$1.77m from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 16% per year.お知らせ • Apr 09Bri-Chem Corp., Annual General Meeting, Jun 20, 2024Bri-Chem Corp., Annual General Meeting, Jun 20, 2024.New Risk • Apr 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 30% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (CA$9.38m market cap, or US$6.91m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin).Reported Earnings • Apr 01Full year 2023 earnings released: EPS: CA$0.03 (vs CA$0.33 in FY 2022)Full year 2023 results: EPS: CA$0.03 (down from CA$0.33 in FY 2022). Revenue: CA$106.0m (up 1.5% from FY 2022). Net income: CA$909.4k (down 90% from FY 2022). Profit margin: 0.9% (down from 8.3% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.分析記事 • Feb 07Bri-Chem Corp.'s (TSE:BRY) Shares Leap 28% Yet They're Still Not Telling The Full StoryBri-Chem Corp. ( TSE:BRY ) shareholders are no doubt pleased to see that the share price has bounced 28% in the last...Board Change • Jan 09Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 17Third quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.019 profit in 3Q 2022)Third quarter 2023 results: CA$0.01 loss per share (down from CA$0.019 profit in 3Q 2022). Revenue: CA$26.8m (down 7.4% from 3Q 2022). Net loss: CA$375.8k (down 175% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 76% per year whereas the company’s share price has increased by 77% per year.分析記事 • Aug 29Bri-Chem Corp.'s (TSE:BRY) Shares Not Telling The Full StoryThere wouldn't be many who think Bri-Chem Corp.'s ( TSE:BRY ) price-to-sales (or "P/S") ratio of 0.1x is worth a...Reported Earnings • Aug 16Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.014 in 2Q 2022)Second quarter 2023 results: EPS: CA$0.02 (up from CA$0.014 in 2Q 2022). Revenue: CA$25.2m (flat on 2Q 2022). Net income: CA$552.9k (up 62% from 2Q 2022). Profit margin: 2.2% (up from 1.3% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has only increased by 74% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 17First quarter 2023 earnings released: EPS: CA$0.01 (vs CA$0.33 in 1Q 2022)First quarter 2023 results: EPS: CA$0.01 (down from CA$0.33 in 1Q 2022). Revenue: CA$27.2m (up 16% from 1Q 2022). Net income: CA$265.2k (down 97% from 1Q 2022). Profit margin: 1.0% (down from 33% in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has only increased by 82% per year, which means it is significantly lagging earnings growth.分析記事 • Mar 31Returns On Capital Are A Standout For Bri-Chem (TSE:BRY)If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Reported Earnings • Mar 31Full year 2022 earnings released: EPS: CA$0.33 (vs CA$0.055 in FY 2021)Full year 2022 results: EPS: CA$0.33 (up from CA$0.055 in FY 2021). Revenue: CA$104.5m (up 73% from FY 2021). Net income: CA$8.64m (up CA$7.33m from FY 2021). Profit margin: 8.3% (up from 2.2% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has increased by 135% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Nov 16Third quarter 2022 earnings released: EPS: CA$0.02 (vs CA$0.015 in 3Q 2021)Third quarter 2022 results: EPS: CA$0.02 (up from CA$0.015 in 3Q 2021). Revenue: CA$29.0m (up 76% from 3Q 2021). Net income: CA$499.9k (up 44% from 3Q 2021). Profit margin: 1.7% (down from 2.1% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 16Second quarter 2022 earnings released: EPS: CA$0.014 (vs CA$0.002 in 2Q 2021)Second quarter 2022 results: EPS: CA$0.014 (up from CA$0.002 in 2Q 2021). Revenue: CA$25.5m (up 83% from 2Q 2021). Net income: CA$341.1k (up CA$296.8k from 2Q 2021). Profit margin: 1.3% (up from 0.3% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 68% per year, which means it is significantly lagging earnings growth.分析記事 • Jun 11Bri-Chem (TSE:BRY) Knows How To Allocate Capital EffectivelyDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Reported Earnings • May 18First quarter 2022 earnings released: EPS: CA$0.32 (vs CA$0.006 in 1Q 2021)First quarter 2022 results: EPS: CA$0.32 (up from CA$0.006 in 1Q 2021). Revenue: CA$23.5m (up 105% from 1Q 2021). Net income: CA$7.77m (up CA$7.63m from 1Q 2021). Profit margin: 33% (up from 1.2% in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 14Bri-Chem Corp., Annual General Meeting, Jun 14, 2022Bri-Chem Corp., Annual General Meeting, Jun 14, 2022.分析記事 • Apr 06We Think That There Are Issues Underlying Bri-Chem's (TSE:BRY) EarningsDespite posting some strong earnings, the market for Bri-Chem Corp.'s ( TSE:BRY ) stock hasn't moved much. Our analysis...Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CA$0.06 (vs CA$0.21 loss in FY 2020)Full year 2021 results: EPS: CA$0.06 (up from CA$0.21 loss in FY 2020). Revenue: CA$60.4m (up 34% from FY 2020). Net income: CA$1.32m (up CA$6.46m from FY 2020). Profit margin: 2.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.分析記事 • Dec 31Bri-Chem's (TSE:BRY) Returns On Capital Are Heading HigherIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Reported Earnings • Nov 20Third quarter 2021 earnings released: EPS CA$0.015 (vs CA$0.078 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CA$16.5m (up 121% from 3Q 2020). Net income: CA$347.8k (up CA$2.21m from 3Q 2020). Profit margin: 2.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 14Second quarter 2021 earnings released: EPS CA$0.003 (vs CA$0.053 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CA$13.9m (up 104% from 2Q 2020). Net income: CA$44.2k (up CA$1.32m from 2Q 2020). Profit margin: 0.3% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Reported Earnings • Apr 03Full year 2020 earnings released: CA$0.22 loss per share (vs CA$0.15 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: CA$45.2m (down 51% from FY 2019). Net loss: CA$5.15m (loss widened 41% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 35% per year whereas the company’s share price has fallen by 36% per year.Reported Earnings • Nov 15Third quarter 2020 earnings released: CA$0.08 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: CA$7.45m (down 66% from 3Q 2019). Net loss: CA$1.86m (loss widened CA$1.69m from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has fallen by 54% per year, which means it is performing significantly worse than earnings.お知らせ • Oct 07Bri-Chem Corp. Appoints Tony Pagnucco as Chief Financial Officer, Effective October 6, 2020Bri-Chem Corp. announced that Tony Pagnucco, CPA, has been appointed Chief Financial Officer, effective October 6, 2020. Mr. Pagnucco will succeed Jason Theiss, who will be stepping down from the CFO role on October 31, 2020 to pursue other interests.株主還元BRYCA Trade DistributorsCA 市場7D7.2%-2.7%-0.5%1Y12.1%45.1%30.2%株主還元を見る業界別リターン: BRY過去 1 年間で45.1 % の収益を上げたCanadian Trade Distributors業界を下回りました。リターン対市場: BRYは、過去 1 年間で30.2 % のリターンを上げたCanadian市場を下回りました。価格変動Is BRY's price volatile compared to industry and market?BRY volatilityBRY Average Weekly Movement11.3%Trade Distributors Industry Average Movement4.4%Market Average Movement9.4%10% most volatile stocks in CA Market16.3%10% least volatile stocks in CA Market3.7%安定した株価: BRY 、 Canadian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: BRYの 週次ボラティリティ ( 11% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト198550Barry Hugghinsbrichem.comブリ・ケム・コーポレーションは、その子会社とともに、北米の石油・ガス業界向けに油田用化学品の卸販売を行っている。同社は、様々な重量の掘削流体製品、粘土、ロストサーキュレーション材料、化学薬品、油泥製品の供給、ブレンド、パッケージ化、および完成、セメンテーション、酸性化、刺激、化学薬品の生産に携わっている。また、ベントナイト、バライト、塩化カルシウム、シダーファイバー、石膏、水和石灰、亜炭、天然ゲル、ソーダ灰を提供し、汎用、特殊掘削、油田セメンチング、工業用化学品を販売している。加えて、粘度、流体損失、潤滑性など様々な分析のための掘削流体の顧客向け試験、流通・物流サービス、セメンチング用化学薬品のブレンドサービスも提供している。同社は1985年に設立され、カナダのアチソンに本社を置く。もっと見るBri-Chem Corp. 基礎のまとめBri-Chem の収益と売上を時価総額と比較するとどうか。BRY 基礎統計学時価総額CA$9.78m収益（TTM）CA$1.48m売上高(TTM)CA$72.26m6.6xPER（株価収益率0.1xP/SレシオBRY は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計BRY 損益計算書（TTM）収益CA$72.26m売上原価CA$57.89m売上総利益CA$14.37mその他の費用CA$12.89m収益CA$1.48m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.056グロス・マージン19.89%純利益率2.04%有利子負債／自己資本比率64.3%BRY の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/04 08:28終値2026/07/30 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bri-Chem Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Sarah HughesATB Cormark Historical (Cormark Securities)Michael MillsBeacon Securities LimitedDavid GalisonCIBC Capital Markets1 その他のアナリストを表示
New Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Market cap is less than US$10m (CA$9.38m market cap, or US$6.59m). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).
Reported Earnings • May 15First quarter 2026 earnings released: EPS: CA$0.01 (vs CA$0.016 loss in 1Q 2025)First quarter 2026 results: EPS: CA$0.01 (up from CA$0.016 loss in 1Q 2025). Revenue: CA$16.6m (down 17% from 1Q 2025). Net income: CA$86.4k (up CA$498.1k from 1Q 2025). Profit margin: 0.5% (up from net loss in 1Q 2025). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 16Bri-Chem Corp., Annual General Meeting, Jun 19, 2026Bri-Chem Corp., Annual General Meeting, Jun 19, 2026. Location: british columbia, vancouver Canada
Reported Earnings • Mar 27Full year 2025 earnings released: EPS: CA$0.04 (vs CA$0.15 loss in FY 2024)Full year 2025 results: EPS: CA$0.04 (up from CA$0.15 loss in FY 2024). Revenue: CA$75.6m (down 9.0% from FY 2024). Net income: CA$979.0k (up CA$4.83m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 18Third quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.01 loss in 3Q 2024)Third quarter 2025 results: EPS: CA$0.01 (up from CA$0.01 loss in 3Q 2024). Revenue: CA$18.2m (down 17% from 3Q 2024). Net income: CA$160.3k (up CA$429.1k from 3Q 2024). Profit margin: 0.9% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Oct 21Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.3% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Market cap is less than US$10m (CA$9.38m market cap, or US$6.59m). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).
Reported Earnings • May 15First quarter 2026 earnings released: EPS: CA$0.01 (vs CA$0.016 loss in 1Q 2025)First quarter 2026 results: EPS: CA$0.01 (up from CA$0.016 loss in 1Q 2025). Revenue: CA$16.6m (down 17% from 1Q 2025). Net income: CA$86.4k (up CA$498.1k from 1Q 2025). Profit margin: 0.5% (up from net loss in 1Q 2025). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 16Bri-Chem Corp., Annual General Meeting, Jun 19, 2026Bri-Chem Corp., Annual General Meeting, Jun 19, 2026. Location: british columbia, vancouver Canada
Reported Earnings • Mar 27Full year 2025 earnings released: EPS: CA$0.04 (vs CA$0.15 loss in FY 2024)Full year 2025 results: EPS: CA$0.04 (up from CA$0.15 loss in FY 2024). Revenue: CA$75.6m (down 9.0% from FY 2024). Net income: CA$979.0k (up CA$4.83m from FY 2024). Profit margin: 1.3% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 18Third quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.01 loss in 3Q 2024)Third quarter 2025 results: EPS: CA$0.01 (up from CA$0.01 loss in 3Q 2024). Revenue: CA$18.2m (down 17% from 3Q 2024). Net income: CA$160.3k (up CA$429.1k from 3Q 2024). Profit margin: 0.9% (up from net loss in 3Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Oct 21Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.3% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Oct 18Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.3% to CA$0.22. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Sep 15Now 24% undervaluedOver the last 90 days, the stock has risen 4.7% to CA$0.23. The fair value is estimated to be CA$0.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.9% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: CA$0.01 (vs CA$0.018 loss in 2Q 2024)Second quarter 2025 results: EPS: CA$0.01 (up from CA$0.018 loss in 2Q 2024). Revenue: CA$20.5m (up 7.5% from 2Q 2024). Net income: CA$156.8k (up CA$644.6k from 2Q 2024). Profit margin: 0.8% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
分析記事 • Jul 30A Piece Of The Puzzle Missing From Bri-Chem Corp.'s (TSE:BRY) 48% Share Price ClimbBri-Chem Corp. ( TSE:BRY ) shareholders would be excited to see that the share price has had a great month, posting a...
Reported Earnings • May 17First quarter 2025 earnings released: CA$0.02 loss per share (vs CA$0.057 loss in 1Q 2024)First quarter 2025 results: CA$0.02 loss per share (improved from CA$0.057 loss in 1Q 2024). Revenue: CA$19.9m (down 6.8% from 1Q 2024). Net loss: CA$411.8k (loss narrowed 73% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 16Bri-Chem Corp., Annual General Meeting, Jun 20, 2025Bri-Chem Corp., Annual General Meeting, Jun 20, 2025. Location: alberta, edmonton Canada
Reported Earnings • Apr 01Full year 2024 earnings released: CA$0.15 loss per share (vs CA$0.034 profit in FY 2023)Full year 2024 results: CA$0.15 loss per share (down from CA$0.034 profit in FY 2023). Revenue: CA$83.1m (down 22% from FY 2023). Net loss: CA$3.85m (down CA$4.76m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.
分析記事 • Dec 13Investors Still Aren't Entirely Convinced By Bri-Chem Corp.'s (TSE:BRY) Revenues Despite 59% Price JumpBri-Chem Corp. ( TSE:BRY ) shares have had a really impressive month, gaining 59% after a shaky period beforehand...
Reported Earnings • Nov 17Third quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.014 loss in 3Q 2023)Third quarter 2024 results: CA$0.01 loss per share (improved from CA$0.014 loss in 3Q 2023). Revenue: CA$22.0m (down 18% from 3Q 2023). Net loss: CA$268.8k (loss narrowed 28% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
分析記事 • Sep 10Some Investors May Be Worried About Bri-Chem's (TSE:BRY) Returns On CapitalIf you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...
Reported Earnings • Aug 16Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.021 profit in 2Q 2023)Second quarter 2024 results: CA$0.02 loss per share (down from CA$0.021 profit in 2Q 2023). Revenue: CA$19.1m (down 24% from 2Q 2023). Net loss: CA$487.8k (down 188% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
分析記事 • May 22Bri-Chem (TSE:BRY) Hasn't Managed To Accelerate Its ReturnsIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
Reported Earnings • May 19First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.01 profit in 1Q 2023)First quarter 2024 results: CA$0.06 loss per share (down from CA$0.01 profit in 1Q 2023). Revenue: CA$21.4m (down 21% from 1Q 2023). Net loss: CA$1.51m (down CA$1.77m from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 16% per year.
お知らせ • Apr 09Bri-Chem Corp., Annual General Meeting, Jun 20, 2024Bri-Chem Corp., Annual General Meeting, Jun 20, 2024.
New Risk • Apr 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 30% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (CA$9.38m market cap, or US$6.91m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin).
Reported Earnings • Apr 01Full year 2023 earnings released: EPS: CA$0.03 (vs CA$0.33 in FY 2022)Full year 2023 results: EPS: CA$0.03 (down from CA$0.33 in FY 2022). Revenue: CA$106.0m (up 1.5% from FY 2022). Net income: CA$909.4k (down 90% from FY 2022). Profit margin: 0.9% (down from 8.3% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.
分析記事 • Feb 07Bri-Chem Corp.'s (TSE:BRY) Shares Leap 28% Yet They're Still Not Telling The Full StoryBri-Chem Corp. ( TSE:BRY ) shareholders are no doubt pleased to see that the share price has bounced 28% in the last...
Board Change • Jan 09Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 17Third quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.019 profit in 3Q 2022)Third quarter 2023 results: CA$0.01 loss per share (down from CA$0.019 profit in 3Q 2022). Revenue: CA$26.8m (down 7.4% from 3Q 2022). Net loss: CA$375.8k (down 175% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 76% per year whereas the company’s share price has increased by 77% per year.
分析記事 • Aug 29Bri-Chem Corp.'s (TSE:BRY) Shares Not Telling The Full StoryThere wouldn't be many who think Bri-Chem Corp.'s ( TSE:BRY ) price-to-sales (or "P/S") ratio of 0.1x is worth a...
Reported Earnings • Aug 16Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.014 in 2Q 2022)Second quarter 2023 results: EPS: CA$0.02 (up from CA$0.014 in 2Q 2022). Revenue: CA$25.2m (flat on 2Q 2022). Net income: CA$552.9k (up 62% from 2Q 2022). Profit margin: 2.2% (up from 1.3% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 91% per year but the company’s share price has only increased by 74% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 17First quarter 2023 earnings released: EPS: CA$0.01 (vs CA$0.33 in 1Q 2022)First quarter 2023 results: EPS: CA$0.01 (down from CA$0.33 in 1Q 2022). Revenue: CA$27.2m (up 16% from 1Q 2022). Net income: CA$265.2k (down 97% from 1Q 2022). Profit margin: 1.0% (down from 33% in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 99% per year but the company’s share price has only increased by 82% per year, which means it is significantly lagging earnings growth.
分析記事 • Mar 31Returns On Capital Are A Standout For Bri-Chem (TSE:BRY)If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Reported Earnings • Mar 31Full year 2022 earnings released: EPS: CA$0.33 (vs CA$0.055 in FY 2021)Full year 2022 results: EPS: CA$0.33 (up from CA$0.055 in FY 2021). Revenue: CA$104.5m (up 73% from FY 2021). Net income: CA$8.64m (up CA$7.33m from FY 2021). Profit margin: 8.3% (up from 2.2% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has increased by 135% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Nov 16Third quarter 2022 earnings released: EPS: CA$0.02 (vs CA$0.015 in 3Q 2021)Third quarter 2022 results: EPS: CA$0.02 (up from CA$0.015 in 3Q 2021). Revenue: CA$29.0m (up 76% from 3Q 2021). Net income: CA$499.9k (up 44% from 3Q 2021). Profit margin: 1.7% (down from 2.1% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 16Second quarter 2022 earnings released: EPS: CA$0.014 (vs CA$0.002 in 2Q 2021)Second quarter 2022 results: EPS: CA$0.014 (up from CA$0.002 in 2Q 2021). Revenue: CA$25.5m (up 83% from 2Q 2021). Net income: CA$341.1k (up CA$296.8k from 2Q 2021). Profit margin: 1.3% (up from 0.3% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 68% per year, which means it is significantly lagging earnings growth.
分析記事 • Jun 11Bri-Chem (TSE:BRY) Knows How To Allocate Capital EffectivelyDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
Reported Earnings • May 18First quarter 2022 earnings released: EPS: CA$0.32 (vs CA$0.006 in 1Q 2021)First quarter 2022 results: EPS: CA$0.32 (up from CA$0.006 in 1Q 2021). Revenue: CA$23.5m (up 105% from 1Q 2021). Net income: CA$7.77m (up CA$7.63m from 1Q 2021). Profit margin: 33% (up from 1.2% in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 4 highly experienced directors. Independent Director Eric Sauze was the last director to join the board, commencing their role in 2007. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 14Bri-Chem Corp., Annual General Meeting, Jun 14, 2022Bri-Chem Corp., Annual General Meeting, Jun 14, 2022.
分析記事 • Apr 06We Think That There Are Issues Underlying Bri-Chem's (TSE:BRY) EarningsDespite posting some strong earnings, the market for Bri-Chem Corp.'s ( TSE:BRY ) stock hasn't moved much. Our analysis...
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CA$0.06 (vs CA$0.21 loss in FY 2020)Full year 2021 results: EPS: CA$0.06 (up from CA$0.21 loss in FY 2020). Revenue: CA$60.4m (up 34% from FY 2020). Net income: CA$1.32m (up CA$6.46m from FY 2020). Profit margin: 2.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
分析記事 • Dec 31Bri-Chem's (TSE:BRY) Returns On Capital Are Heading HigherIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Reported Earnings • Nov 20Third quarter 2021 earnings released: EPS CA$0.015 (vs CA$0.078 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CA$16.5m (up 121% from 3Q 2020). Net income: CA$347.8k (up CA$2.21m from 3Q 2020). Profit margin: 2.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 14Second quarter 2021 earnings released: EPS CA$0.003 (vs CA$0.053 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CA$13.9m (up 104% from 2Q 2020). Net income: CA$44.2k (up CA$1.32m from 2Q 2020). Profit margin: 0.3% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 03Full year 2020 earnings released: CA$0.22 loss per share (vs CA$0.15 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: CA$45.2m (down 51% from FY 2019). Net loss: CA$5.15m (loss widened 41% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 35% per year whereas the company’s share price has fallen by 36% per year.
Reported Earnings • Nov 15Third quarter 2020 earnings released: CA$0.08 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: CA$7.45m (down 66% from 3Q 2019). Net loss: CA$1.86m (loss widened CA$1.69m from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has fallen by 54% per year, which means it is performing significantly worse than earnings.
お知らせ • Oct 07Bri-Chem Corp. Appoints Tony Pagnucco as Chief Financial Officer, Effective October 6, 2020Bri-Chem Corp. announced that Tony Pagnucco, CPA, has been appointed Chief Financial Officer, effective October 6, 2020. Mr. Pagnucco will succeed Jason Theiss, who will be stepping down from the CFO role on October 31, 2020 to pursue other interests.
